Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a ...

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it ...

The cuts to three advanced drug programs were “inevitable” given the company’s “unsustainable cash burn,” one analyst wrote ...

Shares of Recursion Pharmaceuticals ( RXRX -1.48%) fell this week. The stock lost 24% as of market close on Friday. The move ...

Shares of Recursion Pharmaceuticals ( RXRX -11.15%) are tumbling on Tuesday. The stock lost 10.3% as of 2:50 p.m. ET and was ...

A Swiss research center is trying to use innovative technology to help restore bodily functions for paralyzed patients—and even help Parkinson's patients walk smoothly again.

AI business Recursion Pharmaceuticals has narrowed its drug development pipeline, ending or pausing five programmes as it ...